New diabetes clinical trial: A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM

Published on: January 11, 2023 at 11:00AM
Condition:   T2DM (Type 2 Diabetes Mellitus)
Interventions:   Drug: Ecnoglutide high dosage;   Drug: Ecnoglutide low dosage;   Drug: Dulaglutide;   Drug: Metformin
Sponsor:   Hangzhou Sciwind Biosciences Co., Ltd.
Not yet recruiting
https://ift.tt/QMzpUAR